GALIMBERTI STEFANIA

Risca, G., Pelucchi, S., Mariani, R., Botti, M., Capitoli, G., Di Gennaro, F., et al. (2026). Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 24(1 (January 2026)), 141-149 [10.1016/j.cgh.2025.02.033]. Detail

Capitoli, G., Van Abeelen, K., Piga, I., L'Imperio, V., Nobile, M., Besozzi, D., et al. (2025). Well Begun Is Half Done: The Impact of Pre-Processing in MALDI Mass Spectrometry Imaging Analysis Applied to a Case Study of Thyroid Nodules. STATS, 8(3) [10.3390/stats8030057]. Detail

Rossi, A., Romano, R., Fecarotta, S., Dell'Anno, M., Pecorella, V., Passeggio, R., et al. (2025). Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy. MED, 6(4 (11 April 2025)) [10.1016/j.medj.2024.10.021]. Detail

Petrosino, M., Gouvêa Bogossian, E., Rebora, P., Galimberti, S., Chesnut, R., Bouzat, P., et al. (2025). Neurological Pupil Index and Intracranial Hypertension in Patients with Acute Brain Injury: A Secondary Analysis of the ORANGE Study. JAMA NEUROLOGY, 82(2), 176-184 [10.1001/jamaneurol.2024.4189]. Detail

Cazzaniga, M., Pepe, F., Rossi, E., Coltelli, L., Beano, A., Valerio, M., et al. (2025). A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial. CLINICAL BREAST CANCER, 25(6), 560-565 [10.1016/j.clbc.2025.05.003]. Detail